BackProvention Bio Overview

Provention Bio EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PRVB.

Quarterly EBIT

-$40.17M
55.53% YoY

As of Dec 31, 2022

Annual EBIT (TTM)

-$128.16M
11.03% YoY

Trailing 12 months ending Dec 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)